Scientific paper - Original scientific paper
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Journal of Thrombosis and Thrombolysis, 57 (2023), 1; 39-49. https://doi.org/10.1007/s11239-023-02866-y

Ding, Wern Yew; ...; Kes, Vanja Basic; Kalan, Marica Bracic; Brkljacic, Diana Delic; Knezevic, Aleksandar; Kovacic, Dragan; Nazlić, Jurica; Persic, Viktor; Pivac, Nediljko; Poljakovic, Zdravka

Cite this document

Ding, W. Y., Kes, V. B., Kalan, M. B., Brkljacic, D. D., Knezevic, A., Kovacic, D. ... Poljakovic, Z. (2023). Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry. Journal of Thrombosis and Thrombolysis, 57. (1), 39-49. doi: 10.1007/s11239-023-02866-y

Ding, Wern Yew, et al. "Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry." Journal of Thrombosis and Thrombolysis, vol. 57, no. 1, 2023, pp. 39-49. https://doi.org/10.1007/s11239-023-02866-y

Ding, Wern Yew, Vanja Basic Kes, Marica Bracic Kalan, Diana Delic Brkljacic, Aleksandar Knezevic, Dragan Kovacic, Jurica Nazlić, Viktor Persic, Nediljko Pivac and Zdravka Poljakovic. "Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry." Journal of Thrombosis and Thrombolysis 57, no. 1 (2023): 39-49. https://doi.org/10.1007/s11239-023-02866-y

Ding, W. Y., et al. (2023) 'Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry', Journal of Thrombosis and Thrombolysis, 57(1), pp. 39-49. doi: 10.1007/s11239-023-02866-y

Ding WY, Kes VB, Kalan MB, Brkljacic DD, Knezevic A, Kovacic D, and sur.. Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry. Journal of Thrombosis and Thrombolysis [Internet]. 2023 August 11 [cited 2024 October 07];57(1):39-49. doi: 10.1007/s11239-023-02866-y

W. Y. Ding, et al., "Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry", Journal of Thrombosis and Thrombolysis, vol. 57, no. 1, pp. 39-49, August 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:220:023108. [Accessed: 07 October 2024]

Please login to the repository to save this object to your list.